At a glance
ClinicalIndex Comparison RecordPhase 2Unknown· 23 enrolled
Drug / intervention
Robot assisted distal gastrectomy (DaVinci)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Study of Robot Assisted Distal Gastrectomy With Nodal Dissection for Clinical Stage Ia Gastric Cancer
In Brief
A Phase 2 clinical trial evaluating Robot assisted distal gastrectomy (DaVinci) for Early Gastric Cancer. Targeting 23 participants across 1 site.
Detailed Summary
The aim of this study is to clarify safety of robot assisted distal gastrectomy with lymph node dissection in patients with stage Ia early gastric cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEarly Gastric Cancer
CountriesJapan
Collaborators--
Timeline
Phase 2UnknownOverdue
201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2011
First PostedJan 2012
Primary CompletionDec 2012
Study CompletionDec 2017
TodayJul 2026
First PostedJan 6, 2012
Enrollment StartDec 1, 2011
Primary CompletionDec 1, 2012
Study CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 14.5 years ago
Interventions
Robot assisted distal gastrectomy (DaVinci)device
patients who received robot assisted distal gastrectomy